Dr. Brenda W. Cooper
Claim this profileCase Western Reserve University
Studies Acute Myeloid Leukemia
Studies Myeloid Leukemia
11 reported clinical trials
30 drugs studied
Area of expertise
1Acute Myeloid Leukemia
CD33 positive
t(8;21) negative
inv(16) negative
2Myeloid Leukemia
CD33 positive
t(8;21) negative
inv(16) negative
Affiliated Hospitals
Clinical Trials Brenda W. Cooper is currently running
Stem Cell Transplant + Mylotarg
for Acute Myeloid Leukemia
This is a Phase 1/2a, multicenter, open-label, first-in-human (FIH) study of VOR33 in participants with AML or MDS who are undergoing human leukocyte antigen (HLA)-matched allogeneic hematopoietic cell transplant (HCT).
Recruiting1 award Phase 1 & 26 criteria
Lenalidomide + Dexamethasone +/- Daratumumab
for Multiple Myeloma
This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread. Giving lenalidomide and dexamethasone with daratumumab may work better in treating patients with smoldering myeloma.
Recruiting2 awards Phase 312 criteria
More about Brenda W. Cooper
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Brenda W. Cooper has experience with
- VOR33
- Cytarabine
- Dexamethasone
- Ibrutinib
- Uproleselan
- Unlicensed CBU
Breakdown of trials Brenda W. Cooper has run
Acute Myeloid Leukemia
Myeloid Leukemia
Lymphoma
Infusion Reaction
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brenda W. Cooper specialize in?
Brenda W. Cooper focuses on Acute Myeloid Leukemia and Myeloid Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved CD33 positive patients, or patients who are t(8;21) negative.
Is Brenda W. Cooper currently recruiting for clinical trials?
Yes, Brenda W. Cooper is currently recruiting for 4 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Brenda W. Cooper has studied deeply?
Yes, Brenda W. Cooper has studied treatments such as VOR33, Cytarabine, Dexamethasone.
What is the best way to schedule an appointment with Brenda W. Cooper?
Apply for one of the trials that Brenda W. Cooper is conducting.
What is the office address of Brenda W. Cooper?
The office of Brenda W. Cooper is located at: Case Western Reserve University, Cleveland, Ohio 44106 United States. This is the address for their practice at the Case Western Reserve University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.